Artificial Intelligence Innovation in Alzheimer's Disease Care, Diagnosis, Treatment, and Integration

Authors

Deepak Kumar Yadav
Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Vishwavidyalaya, Sagar, Madhya Pradesh
Afaroj Alam
Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Vishwavidyalaya, Sagar, Madhya Pradesh
Dr. Dharmendra Jain
Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Vishwavidyalaya, Sagar, Madhya Pradesh

Synopsis

Alzheimer's disease (AD) is a progressive illness that impacts daily activity, thinking, and memory. Conventional diagnosis and therapy are burdensome given delayed drug development, delayed detection, and inadequate support for caregivers and patients. To fill these gaps AI has become a useful resource providing new data-driven approaches to controlling AD. AI innovation in patient care, diagnosis, treatment, and integration in healthcare is explored in this article. Machine learning that previously employed imaging methods such as MRI, PET, and CT enhances mild cognitive impairment diagnosis and follows the disease progression when coupled with tools such as the Alzheimer's disease Neuroimaging Initiative (ADNI). Natural language processing facilitates early screening and improves cognitive and linguistic testing. Through the analysis of current drugs, creation of new therapeutic drugs, forecasting patient reactions to medication, and performing virtual molecular docking, which accelerates discovery, AI assists with the therapeutic process. In patient care, AI-enabled digital therapies, smart assistive technology, chatbots, and remote monitoring features provide caregivers improved support, daily care, and cognitive rehabilitation. With AI integrated into the health care system by telemedicine, electronic health records, and real-time decision support, clinical decision making can be enhanced. But data quality, clarity of models, law, cost, and access problems still have to be addressed. In the future, ensuring responsible usage will necessitate interdisciplinary collaboration and ethics. With its potential to enhance clinical outcomes and quality of life, AI presents an attractive strategy to enhance Alzheimer's disease diagnosis, treatment, and care in general.

Keywords: Artificial intelligence (AI), MRI, Positron emission tomography (PET), Alzheimer's Disease Neuroimaging Initiative (ADNI), Electronic Health Records, Machine learning (ML), Deep Learning (DL).

 

Author Biographies

Deepak Kumar Yadav, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Vishwavidyalaya, Sagar, Madhya Pradesh

Deepak Kumar Yadav is a Ph.D. research scholar in Pharmaceutics at the Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He was born in Ghazipur, Uttar Pradesh.His research interests focus on nanomedicine and nanotechnology, with an emphasis on the design and development of advanced drug delivery systems. He is passionate about innovation in pharmaceutical formulation and aims to contribute to the advancement of effective and patient-friendly therapeutic technologies.

Afaroj Alam, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Vishwavidyalaya, Sagar, Madhya Pradesh

Afaroj Alam is a Ph.D. research scholar in the Department of Pharmaceutical Sciences at Dr. Harisingh Gour University, Sagar, India. His academic journey is driven by a strong foundation in chemistry, which shapes his scientific approach and fuels his interest in advanced pharmaceutical research. He aspires to build a career in academia and research, continuing to explore innovative solutions that bridge chemistry and pharmaceutical technology.

Dr. Dharmendra Jain, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Vishwavidyalaya, Sagar, Madhya Pradesh

Dharmendra Jain is serving as an Assistant Professor of Pharmaceutics in the Dept. of Pharm. Sciences, Dr. H. S. Gour University, Sagar, India (Sept 2013-till date. He has supervised more than 50 students for their masters project. He completed his PhD from School of Biosciences and Bioengineering, IIT Bombay, Mumbai. He has done Postdoc from Copenhagen University, Denmark. He has more than 30 publications in national and international journals and books.

Published

March 1, 2025

How to Cite

Artificial Intelligence Innovation in Alzheimer’s Disease Care, Diagnosis, Treatment, and Integration. (2025). In Smart Pharmaceutics: Integrating Computational Intelligence, Nanomedicine, and Green Chemistry. RSYN RESEARCH. https://doi.org/10.70130/